JPRN-C000000276已完成未知
A controlled trial of zinc supplementation for decompensated liver cirrhosis - A controlled trial of zinc supplementation for decompensated LC
HO IwakuniClinical Center0 个研究点目标入组 90 人开始时间: 2008年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.The patient with pregnancy or gravid possibility. 2.Advanced HCC, or other malignancy, its prognosis is less than 1 year. 3.Less than 2.5g/ml of serum albumin level 4.More than 3.0mg/dl of total bil. 5.Hepatic encephalopathy (possible anamnestic case) is higher than 3 degree. 6. The patients whom judged to be inadequate by clinical trial liability or clinical trial allotment doctor.
研究者
相似试验
已完成
1 期
Effects of Zinc Supplementation on Improving Immune Function in Patients with SepsisSepsisJPRN-jRCTs051220200Inoue Shigeaki
已完成
Unknown
Study to confirm the effect of supplement intake on functional improvement in healthy men and womeJPRN-UMIN000047388Yamazaki Otolaryngology Clinic60
尚未招募
Unknown
A study to evaluate the effects of a supplement on skin conditionsJPRN-UMIN000046821KANEKA CORPORATIO80
招募中
3 期
Vitamin D and Cognition TrialMild Cognitive Impairment and vitamin D (25-hydroxyvitamin D) blood concentration between 50 nmol/L and 12.5 nmol/L.Mental Health - Studies of normal psychology, cognitive function and behaviourDiet and Nutrition - Other diet and nutrition disordersACTRN12607000321448Professor Nicola Lautenschlager110
招募中
不适用
utritional Supplementation in children with Type 1 Diabetes MellitusCTRI/2017/08/009522Hirabai Cowasji Jehangir Medical Research Institute280